Status:

TERMINATED

Noninvasive Blood Glucose Monitoring Method Based on Imaging of the Eye

Lead Sponsor:

University of Toledo Health Science Campus

Collaborating Sponsors:

University of Toledo

Conditions:

Diabetes

Eligibility:

All Genders

18-75 years

Brief Summary

Previous animal studies done by Dr. Brent Cameron in 2013 at the Univ. of Toledo have shown that glucose present in the fluid in the front of the eye, called the aqueous humor, correlates well with bl...

Eligibility Criteria

Inclusion

  • Diagnosis of Diabetes Type 1 and 2 and can be verified by the principal investigator

Exclusion

  • Patients with any disease or abnormality of the eye
  • Patients who are mentally incapacitated, cognitively impaired or with severe psychological disorders and cannot sign consent on their own

Key Trial Info

Start Date :

August 1 2014

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

May 1 2015

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT02236364

Start Date

August 1 2014

End Date

May 1 2015

Last Update

August 13 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Toledo, Health Science Campus

Toledo, Ohio, United States, 43614